Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Neonatology

Free Subscription Articles published in Lancet Retrieve available abstracts of 47 articles: HTML format

Single Articles

January 2026
1. KIMATHI D, Juan-Giner A, Bob NS, Orindi B, et al
   Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
   Lancet. 2026 Jan 13:S0140-6736(25)02069-0. doi: 10.1016/S0140-6736(25)02069.
   PubMed     Abstract available
   
   
   
2. TURTLE L
   Yellow fever vaccine minimum fractional dosing does not extend to infants.
   Lancet. 2026 Jan 13:S0140-6736(25)02364-5. doi: 10.1016/S0140-6736(25)02364.
   PubMed    
   
   
   
3. YANG YT
   A risky rollback on hepatitis B birth dose in the USA.
   Lancet. 2026 Jan 9:S0140-6736(25)02630-3. doi: 10.1016/S0140-6736(25)02630.
   PubMed    
   
   
   December 2025
4. ZAIGHAM M, Visser GHA, Galadanci H
   Announcing the Lancet Commission on Maternal and Newborn Health.
   Lancet. 2025 Dec 23:S0140-6736(25)02599-1. doi: 10.1016/S0140-6736(25)02599.
   PubMed    
   
   
   
5. GENC K
   Turkiye rocked by newborn care scandal.
   Lancet. 2025;404:2503-2504.
   PubMed    
   
   
   
6. VAKANIAKI EH, Barhishindi I, Mubiala A, Malembaka EB, et al
   Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study.
   Lancet. 2025 Dec 19:S0140-6736(25)02309-8. doi: 10.1016/S0140-6736(25)02309.
   PubMed     Abstract available
   
   
   
7. GOADSBY J, Syngelaki A, Magee LA, von Dadelszen P, et al
   Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial.
   Lancet. 2025 Dec 4:S0140-6736(25)01207-3. doi: 10.1016/S0140-6736(25)01207.
   PubMed     Abstract available
   
   
   November 2025
8. GUPTA S, Darmstadt GL, Kirkwood B, Ashorn P, et al
   A clinical practice guide to transform care and save newborn lives with kangaroo mother care.
   Lancet. 2025 Nov 14:S0140-6736(25)02173-7. doi: 10.1016/S0140-6736(25)02173.
   PubMed    
   
   
   October 2025
9. ABDOOL KARIM Q, Mohan J, Bhutta ZA
   Advancing women, maternal, newborn, and child health equity.
   Lancet. 2025 Oct 10:S0140-6736(25)01920-8. doi: 10.1016/S0140-6736(25)01920.
   PubMed    
   
   
   September 2025
10. VAN DER WINDT LI, Oudijk MA
    Atosiban for threatened preterm birth: the APOSTEL 8 trial - Authors' reply.
    Lancet. 2025;406:1339-1340.
    PubMed    
    
    
    
11. ZEGARRA RR, Valentini B, Ghi T
    Atosiban for threatened preterm birth: the APOSTEL 8 trial.
    Lancet. 2025;406:1339.
    PubMed    
    
    
    
12. LOUSSERT L, Garabedian C, Dupuis N, Bujold E, et al
    Atosiban for threatened preterm birth: the APOSTEL 8 trial.
    Lancet. 2025;406:1338-1339.
    PubMed    
    
    
    August 2025
13. IRFAN B, Abuhaiba S, Abusultan M, Nassar O, et al
    Is Gaza still a place for newborn life?
    Lancet. 2025;406:803.
    PubMed    
    
    
    July 2025
14. CLARK H, Khosla R
    The Partnership for Maternal, Newborn, and Child Health: 2026-30 strategy.
    Lancet. 2025 Jul 24:S0140-6736(25)01519-3. doi: 10.1016/S0140-6736(25)01519.
    PubMed    
    
    
    
15. DUGDALE CM, Ufio O, Giardina J, Shebl F, et al
    Estimating the effect of maternal viral load on perinatal and postnatal HIV transmission: a systematic review and meta-analysis.
    Lancet. 2025 Jul 10:S0140-6736(25)00765-2. doi: 10.1016/S0140-6736(25)00765.
    PubMed     Abstract available
    
    
    June 2025
16. FERNANDEZ TURIENZO C, November L, Kamara M, Conteh O, et al
    Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial.
    Lancet. 2025 Jun 18:S0140-6736(25)00454-4. doi: 10.1016/S0140-6736(25)00454.
    PubMed     Abstract available
    
    
    
17. HODNETT E
    A community-based landmark trial to save the lives of pregnant adolescents and their newborns in sub-Saharan Africa.
    Lancet. 2025 Jun 18:S0140-6736(25)00731-7. doi: 10.1016/S0140-6736(25)00731.
    PubMed    
    
    
    May 2025
18. YANG XY, Zhang GJ, Zhou YB
    Positive RPR and TPLA tests cannot confirm congenital syphilis.
    Lancet. 2025;405:1663.
    PubMed    
    
    
    
19. HIRATE T, Shinoda K, Tetsuka N
    Positive RPR and TPLA tests cannot confirm congenital syphilis - Authors' reply.
    Lancet. 2025;405:1663-1664.
    PubMed    
    
    
    April 2025
20. SY I, Sarr SC, Doucoure A
    Strengthening health systems and accountability: Senegal's path to success in reproductive, maternal, newborn, and child health.
    Lancet. 2025 Apr 9:S0140-6736(25)00616-6. doi: 10.1016/S0140-6736(25)00616.
    PubMed    
    
    
    March 2025
21. MAKAMA M, Vogel JP
    Atosiban and managing women in preterm labour.
    Lancet. 2025 Mar 3:S0140-6736(25)00402-7. doi: 10.1016/S0140-6736(25)00402.
    PubMed    
    
    
    
22. VAN DER WINDT LI, Klumper J, Duijnhoven RG, Kok M, et al
    Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial.
    Lancet. 2025 Mar 3:S0140-6736(25)00295-8. doi: 10.1016/S0140-6736(25)00295.
    PubMed     Abstract available
    
    
    February 2025
23. CIDECIYAN AV, Aleman TS
    Gene therapy for young children with congenital blindness.
    Lancet. 2025;405:601-603.
    PubMed    
    
    
    November 2024
24. NORHEIM OF, Chang AY, Bolongaita S, Barraza-Llorens M, et al
    Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions.
    Lancet. 2024 Nov 20:S0140-6736(24)02417-6. doi: 10.1016/S0140-6736(24)02417.
    PubMed     Abstract available
    
    
    
25. BLENCOWE H, Hug L
    Counting every newborn: liveborn or stillborn.
    Lancet. 2024 Nov 4:S0140-6736(24)02250-5. doi: 10.1016/S0140-6736(24)02250.
    PubMed    
    
    
    
26. IRFAN B, Abu Shammala A, Saleh K
    Will there be a future for newborns in Gaza?
    Lancet. 2024;404:1725-1726.
    PubMed    
    
    
    October 2024
27. JAMISON DT, Summers LH, Chang AY, Karlsson O, et al
    Global health 2050: the path to halving premature death by mid-century.
    Lancet. 2024;404:1561-1614.
    PubMed    
    
    
    September 2024
28. IMANI-MUSIMWA P, Ververs M
    Mpox and breastmilk: for once, can we act in time?
    Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
    PubMed    
    
    
    
29. HIRATE T, Kanda K, Ohshima Y, Shinoda K, et al
    Congenital syphilis in a 2-month-old infant during Japanese outbreak.
    Lancet. 2024;404:971.
    PubMed    
    
    
    
30. YANG P, Pardon LP, Ho AC, Lauer AK, et al
    Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study.
    Lancet. 2024;404:962-970.
    PubMed     Abstract available
    
    
    
31. SINGH T, Kumar D
    Perinatal risk in India's Scheduled Tribes.
    Lancet. 2024;404:933-934.
    PubMed    
    
    
    July 2024
32. BERKLEY JA, Walson JL, Bahl R, Rollins N, et al
    Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact.
    Lancet. 2024 Jul 25:S0140-6736(24)00750-5. doi: 10.1016/S0140-6736(24)00750.
    PubMed     Abstract available
    
    
    
33. SERMET-GAUDELUS I, Benaboud S, Bui S, Bihouee T, et al
    Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis.
    Lancet. 2024;404:117-120.
    PubMed    
    
    
    
34. SAMARASEKERA U
    Nahya Salim Masoud: improving newborn health in Tanzania.
    Lancet. 2024;404:19.
    PubMed    
    
    
    June 2024
35. STRUNK T, Molloy EJ, Mishra A, Bhutta ZA, et al
    Neonatal bacterial sepsis.
    Lancet. 2024 Jun 26:S0140-6736(24)00495-1. doi: 10.1016/S0140-6736(24)00495.
    PubMed     Abstract available
    
    
    
36. DEVI S
    Challenges for infant schistosomiasis treatment.
    Lancet. 2024;403:2682.
    PubMed    
    
    
    
37. BEATTIE A, Moore A, Ramagopalan SV
    Genericisation in cost-effectiveness analysis of cystic fibrosis medicines.
    Lancet. 2024;403:2591-2592.
    PubMed    
    
    
    May 2024
38. TUMUKUNDE V, Medvedev MM, Tann CJ, Mambule I, et al
    Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA): a parallel-group, individually randomised controlled trial and economic evaluation.
    Lancet. 2024 May 13:S0140-6736(24)00064-3. doi: 10.1016/S0140-6736(24)00064.
    PubMed     Abstract available
    
    
    March 2024
39. DADOUN S, Demmler-Harrison GJ, Ketwaroo P, Castro EC, et al
    Congenital toxoplasmosis of the brain caused by infection in late pregnancy.
    Lancet. 2024;403:1081-1082.
    PubMed    
    
    
    
40. EWER AK, Edi-Osagie N, Adams E
    Newborn pulse oximetry screening: time for equity in the UK?
    Lancet. 2024 Mar 11:S0140-6736(24)00417-3. doi: 10.1016/S0140-6736(24)00417.
    PubMed    
    
    
    February 2024
41. OKWARAJI YB, Krasevec J, Bradley E, Conkle J, et al
    National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis.
    Lancet. 2024 Feb 28:S0140-6736(23)01198-4. doi: 10.1016/S0140-6736(23)01198.
    PubMed     Abstract available
    
    
    
42. YANG Z, Chang S
    Accelerating the progress of low birthweight reduction.
    Lancet. 2024 Feb 28:S0140-6736(23)01669-0. doi: 10.1016/S0140-6736(23)01669.
    PubMed    
    
    
    
43. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    PubMed    
    
    
    
44. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    PubMed    
    
    
    
45. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    PubMed    
    
    
    
46. OCHOGE M, Futa AC, Umesi A, Affleck L, et al
    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
    Lancet. 2024 Feb 22:S0140-6736(23)02844-1. doi: 10.1016/S0140-6736(23)02844.
    PubMed     Abstract available
    
    
    October 2023
47. COUSINS S
    Expanding access to breastmilk banks.
    Lancet. 2023;402:1514-1515.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neonatology is free of charge.